In addition, pharmacological inhibition of sphK1 by DMS have been shown to exacerbate the infection by increasing disease promoting ERK1/2 induced IL-10 secretion, while on the other hand, decreasing p38 activated IL-12 production. The gene discussed is MAPK3; the disease is infection.